


The Fund seeks to achieve a combination of income and some capital growth.
| Name | % Net Assets | 
|---|---|
| BP | 7.7% | 
| Vodafone | 6.9% | 
| Royal Dutch Shell B | 6.7% | 
| HSBC | 6.5% | 
| Astrazeneca | 5.4% | 
| Glaxosmithkline | 4.7% | 
| National Grid | 3.8% | 
| British American Tobacco | 3.7% | 
| BAE Systems | 2.7% | 
| Aviva | 2.6% | 
| Key | % Net Assets | 
|---|---|
| 7.7% | |
| 6.9% | |
| 6.7% | |
| 6.5% | |
| 72.2% | 
| Date | 20-Aug-2025 | 
|---|---|
| Bid | 905.80p | 
| Offer | 905.80p | 
| Currency | GBP | 
| Change | 2.60p | 
| % | 0.29% | 
| YTD change | 98.50p | 
| YTD % | 12.20% | 
| Fund Inception | 06/04/1984 | 
|---|---|
| Fund Manager | Martin Cholwill | 
| TER | 1.34 (30-Sep-2010) | 
| Minimum Investment | |
|---|---|
| Initial | £1000 | 
| Additional | n/a | 
| Savings | £50 | 
| Charges | |
|---|---|
| Initial | 4.00% | 
| Annual Mang't | 1.25% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.01 | 
| Sharpe ratio | 0.10 | 
You are here: research